Systemic vascular effects of thrombin and thrombin receptor activating peptide in rats

被引:11
|
作者
Sicker, T [1 ]
Wuchold, F [1 ]
Kaiser, B [1 ]
Glusa, E [1 ]
机构
[1] Univ Jena, Fac Med, Ctr Vasc Biol & Med, Unit Expt Angiol, D-99089 Erfurt, Germany
关键词
thrombin; TRAP; vascular effects; blood pressure;
D O I
10.1016/S0049-3848(00)00429-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The proteolytic enzyme thrombin activates its receptor by cleavage of a peptide from the extracellular N-terminus. The newly generated N-terminus acts as a tethered ligand to activate the receptor. Receptor-mediated cellular effects of thrombin can be mimicked by synthetic peptides, which correspond to the amino acid sequence of the newly formed N-terminus. The aim of the present study was to investigate vascular effects of thrombin and the thrombin receptor activating peptide (TRAP: SFLLRN) in vitro and in vivo in rats. In precontracted rat aortic rings, both thrombin (0.3, 1, 3 U/ml) and TRAP (1, 3, 10, 20, 40 muM) induced endothelium-dependent relaxant responses. In anaesthetized rats, the mean arterial blood pressure (MAP) was measured continuously in the carotid artery by a pressure transducer. Thrombin and TRAP were administered as intravenous bolus injection via the femoral vein. Thrombin at doses of 3-100 U/kg, as well as TRAP at doses of 0.1 -0.6 mg/ kg iv, caused a reversible decrease in MAP. Administration of TRAP at doses of 0.3 and 0.6 mg/kg led to a triphasic response in most of the animals treated (50% and 75%, respectively), i.e. a short drop of MAP was followed by an increase and finally a longer lasting decrease in MAP. Pretreatment with the nitric oxide (NO)-synthase inhibitor N-G-nitro-L-arginine-methylester (L-NAME) suppressed the dose-dependent vasodilator effects of thrombin. Heparin and hirudin also inhibited the hypotensive response to thrombin. The TRAP-induced triphasic reaction on MAP was not affected by the serotonin antagonists ketanserin and tropisetron, as well as the aminopeptidase inhibitor amastatin. Pretreatment with L-NAME led to an inhibition of hypotension induced by TRAP at 0.1 mg/kg, as well as of the initial transient fall in blood pressure at doses of 0.3 and 0.6 mg/kg. The studies suggest that the thrombin- and TRAP-induced vasodilation in vitro and in vivo is in part due to the release of endothelial NO. In the blood pressure response to TRAP, additional effects seem to be involved. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:467 / 475
页数:9
相关论文
共 50 条
  • [21] STRUCTURE-ACTIVITY STUDIES OF THE THROMBIN RECEPTOR ACTIVATING PEPTIDE
    SABO, T
    GURWITZ, D
    MOTOLA, L
    BRODT, P
    BARAK, R
    ELHANATY, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 188 (02) : 604 - 610
  • [22] Ionic contrast media inhibit thrombin receptor mediated activation of platelets. Studies with gamma thrombin and thrombin receptor activating peptide (TRAP).
    Fareed, J
    Iqbal, O
    Hoppensteadt, D
    Fu, KD
    Yang, L
    FASEB JOURNAL, 1997, 11 (03): : 1824 - 1824
  • [23] Synergistic actions of a thrombin-derived synthetic peptide and a thrombin receptor-activating peptide in stimulating fibroblast mitogenesis
    Hollenberg, MD
    Mokashi, S
    Leblond, L
    DiMaio, J
    JOURNAL OF CELLULAR PHYSIOLOGY, 1996, 169 (03) : 491 - 496
  • [24] THE ROLE OF THROMBIN AND THROMBIN RECEPTOR ACTIVATING PEPTIDE (TRAP-508) IN INITIATION OF TISSUE-REPAIR
    STIERNBERG, J
    REDIN, WR
    WARNER, WS
    CARNEY, DH
    THROMBOSIS AND HAEMOSTASIS, 1993, 70 (01) : 158 - 162
  • [25] Ionic contrast media inhibit thrombin receptor-mediated activation of platelets: Studies with [001a] thrombin and thrombin receptor-activating peptide
    Fareed, J
    Iqbal, O
    Hoppensteadt, D
    Koza, M
    Moncada, R
    RADIOLOGY, 1996, 201 : 1009 - 1009
  • [26] Determination of the putative binding sites for thrombin receptor activating peptide on platelet thrombin receptor through a hydropathic complementary approach
    Suttnar, J
    Dyr, JE
    Mares, M
    Dolecková, L
    THROMBOSIS AND HAEMOSTASIS, 1999, : 94 - 94
  • [27] MECHANISM OF THE PLATELET ACTIVATION-INDUCED BY THROMBIN RECEPTOR ACTIVATING PEPTIDE
    SEBASTIANI, S
    PESCIOTTI, M
    PIGNATELLI, P
    RIONDINO, S
    GAZZANIGA, PP
    PULCINELLI, FM
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 992 - 992
  • [28] THROMBIN RECEPTOR ACTIVATING PEPTIDE DOES NOT STIMULATE PLATELET PROCOAGULANT ACTIVITY
    GOODWIN, CA
    WHEELERJONES, CPD
    KAKKAR, VV
    DEADMAN, JJ
    AUTHI, KS
    SCULLY, MF
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (01) : 321 - 327
  • [29] DIFFERENT ABILITIES OF THROMBIN RECEPTOR ACTIVATING PEPTIDE AND THROMBIN TO INDUCE PLATELET CALCIUM RISE AND FULL RELEASE REACTION
    LASNE, D
    DONATO, J
    FALET, H
    RENDU, F
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (05) : 1323 - 1328
  • [30] Thrombin receptor-activating peptide releases arachidonic acid from human platelets: A comparison with thrombin and trypsin
    McNicol, A
    Robson, CA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 281 (02): : 861 - 867